Denmark's economic growth, which was driven by what economists described as an "exceptional surge" in pharmaceutical exports, is expected to weaken this year. The looming threat of U.S. tariffs on the ...
Novo Nordisk's weight on GDP, jobs, and exports is reshaping Denmark's growth story despite layoffs and tariff headwinds.
From both a biomedical and economic point of view, the success of the new class of weight-loss drugs is something to behold. Not only are they a remarkable scientific achievement, but — in the case of ...